Robert Alfred John Challiss

Robert Alfred John Challiss

Auto-generated profile, based on publicly available information

Robert Alfred John Challiss

University of Leicester

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1991 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
CNC.David Nicholson
C.David Nicholson
RCR.A.John Challiss
R.A.John Challiss
MSMohammed Shahid
Mohammed Shahid

1 July 1995 in Trends in Neurosciences
Verified
Journal Article
Closed access
PSPeter B. Simpson
Peter B. Simpson
RCR.A. John Challiss
R.A. John Challiss
SNStefan R. Nahorski
Stefan R. Nahorski

1 November 2001 in Biochemical Journal
Verified
Journal Article
Closed access
EHEmmanuel Hermans
Emmanuel Hermans
RCR.A. John Challiss
R.A. John Challiss
In 1991 a new type of G-protein-coupled receptor (GPCR) was cloned, the type 1a metabotropic glutamate (mGlu) receptor, which, despite possessing the defining seven-transmembrane topology of the GPCR superfamily, bore little resemblance to the growing number of other cloned GPCRs. Subsequent studies have shown that there are eight mammalian mGlu receptors that, together with the calcium-sensing receptor, the GABA(B) receptor (where GABA is gamma-aminobutyric acid) and a subset of pheromone, olfactory and taste receptors, make up GPCR family C. Currently available data suggest that family C GPCRs share a number of structural, biochemical and regulatory characteristics, which differ markedly from those of the other GPCR families, most notably the rhodopsin/family A GPCRs that have been most widely studied to date. This review will focus on the group I mGlu receptors (mGlu1 and mGlu5). This subgroup of receptors is widely and differentially expressed in neuronal and glial cells within the brain, and receptor activation has been implicated in the control of an array of key signalling events, including roles in the adaptative changes needed for long-term depression or potentiation of neuronal synaptic connectivity. In addition to playing critical physiological roles within the brain, the mGlu receptors are also currently the focus of considerable attention because of their potential as drug targets for the treatment of a variety of neurological and psychiatric disorders.

1 April 1994 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
RERichard M. Eglen
Richard M. Eglen
HRHelen Reddy
Helen Reddy
NWNikki Watson
Nikki Watson
RCR.A.JOhn Challiss
R.A.JOhn Challiss

1 December 1988 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RCR.A. John Challiss
R.A. John Challiss
IBIan H. Batty
Ian H. Batty
SNStefan R. Nahorski
Stefan R. Nahorski

1 January 1991 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
SNStefan R. Nahorski
Stefan R. Nahorski
CRC. Ian Ragan
C. Ian Ragan
RCR.A.JOhn Challiss
R.A.JOhn Challiss